Akero Therapeutics, Inc. Stock Split Ratio
Akero Therapeutics, Inc. had Stock Split Ratio of 307.42% as of 2019-06-06, per its 10-K filed 2022-02-25.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-02-25
- 2019-06-06: Stockholders' Equity Note, Stock Split, Conversion Ratio 307.42%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2019-06-06 | 307.42% 10-K · filed 2022-02-25 |